CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-11.05%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.3B
AUM Growth
+$2.3B
(-17%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-7.7%
Top 10 Holdings %
Top 10 Hldgs %
58.87%
Holding
47
New
10
Increased
12
Reduced
5
Closed
7
Top Buys
| 1 |
Select Medical
SEM
|
$70.9M |
| 2 |
Tenet Healthcare
THC
|
$51.2M |
| 3 |
Dentsply Sirona
XRAY
|
$44.7M |
| 4 |
Sarepta Therapeutics
SRPT
|
$35.6M |
| 5 |
Exelixis
EXEL
|
$28.1M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$149M |
| 2 |
Merck
MRK
|
$123M |
| 3 |
Universal Health Services
UHS
|
$86.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$84.7M |
| 5 |
Medtronic
MDT
|
$55.5M |
Sector Composition
| 1 | Healthcare | 97.09% |
| 2 | Technology | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viatris
VTRS
$12.3B
| $241M | 10.45% | 23,000,000 | – | – |
|
2
Sanofi
SNY
$121B
| $200M | 8.68% | 4,000,000 | – | – |
|
3
Zimmer Biomet
ZBH
$21B
| $142M | 6.15% | 1,350,000 | – | – |
|
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $139M | 6.02% | 1,850,000 +475,000 | +35% | +$35.6M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $124M | 5.39% | 1,500,000 +200,000 | +15% | +$16.6M |
|
6
Perrigo
PRGO
$3.27B
| $112M | 4.84% | 2,750,000 +250,000 | +10% | +$10.1M |
|
|
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
| $107M | 4.65% | 2,825,000 +425,000 | +18% | +$16.1M |
|
8
Ionis Pharmaceuticals
IONS
$6.8B
| $100M | 4.34% | 2,700,000 -300,000 | -10% | -$11.1M |
|
9
PTC Therapeutics
PTCT
$3.92B
| $98.1M | 4.26% | 2,450,000 +700,000 | +40% | +$28M |
|
|
10
Select Medical
SEM
$1.61B
| $94.5M | 4.1% | 4,000,000 +3,000,000 | +300% | +$70.9M |
|
11
Incyte
INCY
$16.5B
| $91.2M | 3.96% | 1,200,000 -150,000 | -11% | -$11.4M |
|
12
Myriad Genetics
MYGN
$593M
| $90.9M | 3.94% | 5,000,000 +1,500,000 | +43% | +$27.3M |
|
|
13
Tenet Healthcare
THC
$16.3B
| $86.7M | 3.76% | 1,650,000 +975,000 | +144% | +$51.2M |
|
|
14
Universal Health Services
UHS
$11.6B
| $75M | 3.26% | 745,000 -855,000 | -53% | -$86.1M |
|
15
Brookdale Senior Living
BKD
$1.83B
| $72.6M | 3.15% | 16,000,000 | – | – |
|
|
CHNG
16
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $53.6M | 2.33% | 2,325,000 -3,675,000 | -61% | -$84.7M |
|
|
RETA
17
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $45.6M | 1.98% | 1,500,000 | – | – |
|
|
18
Dentsply Sirona
XRAY
$2.85B
| $44.7M | 1.94% | +1,250,000 | New | +$44.7M |
|
|
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $43.6M | 1.89% | 650,000 -550,000 | -46% | -$36.9M |
|
|
20
Exelixis
EXEL
$10.1B
| $34.4M | 1.49% | 1,650,000 +1,350,000 | +450% | +$28.1M |
|
21
ZimVie
ZIMV
$532M
| $32M | 1.39% | 2,000,000 | – | – |
|
22
Evolent Health
EVH
$1.12B
| $30.7M | 1.33% | 1,000,000 +814,600 | +439% | +$25M |
|
23
Biogen
BIIB
$19.4B
| $25.5M | 1.11% | +125,000 | New | +$25.5M |
|
|
NUVA
24
DELISTED
NuVasive, Inc.
NUVA
| $24.6M | 1.07% | 500,000 | – | – |
|
25
Align Technology
ALGN
$10.3B
| $23.7M | 1.03% | +100,000 | New | +$23.7M |
|